Cogenics

Cogenics was a global genomics services company that provided comprehensive molecular biology solutions to the pharmaceutical and biotechnology industries. The company specialized in DNA sequencing, genotyping, and gene expression analysis, operating under strict GLP and CLIA regulatory standards to support clinical trials and drug discovery. Formed as a division of Clinical Data, Inc. through the merger of Genaissance Discovery Services and Lark Technologies, Cogenics maintained a significant presence in both North America and Europe. Its services were instrumental in the field of pharmacogenomics, assisting clients in identifying genetic biomarkers for patient stratification. In 2009, Beckman Coulter acquired Cogenics for approximately 15.4 million dollars to expand its presence in the genomic research services market.